Jeffrey K Aronson
MA DPhil FRCP HonFBPhS HonFFPM
Consultant Physician and Clinical Pharmacologist
Research
- Methods of classifying, detecting, and reporting adverse drug reactions, including systematic reviews, meta-analyses, and the use of anecdotal reports
- Innovation in drug therapy
- Monitoring therapy in chronic disease
- Systematic reviews of pharmacokinetics, pharmacodynamics, and pharmacokinetic–pharmacodynamic modelling
- The role of mechanisms in the philosophy of evidence-based medicine
- Linguistic aspects of medicine and pharmacology
Teaching and training
- Teaching medical students the fundamentals of therapeutics.
- Ad hoc two-week special study modules in clinical pharmacology and therapeutics for medical students.
- Masterclass in prescribing for medical students
- Co-author of didactic textbooks (e.g. “The Oxford Handbook of Practical Drug Therapy”) and contributor of chapters to others
- Editor, Meyler’s Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions (16th edition, 2015) and of its annual updates, Side Effects of Drugs Annuals 1-35
- Co-editor (with John Talbot), Stephens’ Detection and Evaluation of Adverse Drug Reactions: Principles and Practice. 6th edition
Policy
- President Emeritus, Honorary Fellow, and Vice-President Publications, British Pharmacological Society; Vice President Publications
- Member of the Advisory Board of the British National Formulary
- Chairman of the British Pharmacopoeia Commission’s Expert Advisory Group on Nomenclature
Key publications
-
Delays in the post-marketing withdrawal of drugs to which deaths have been attributed: A systematic investigation and analysis
Journal article
Onakpoya IJ. et al, (2015), BMC Medicine, 13
-
Quantifying the effects of diuretics and β-adrenoceptor blockers on glycaemic control in diabetes mellitus - A systematic review and meta-analysis
Journal article
Hirst JA. et al, (2015), British Journal of Clinical Pharmacology, 79, 733 - 743
-
The law of mass action and the pharmacological concentration-effect curve: Resolving the paradox of apparently non-dose-related adverse drug reactions
Journal article
(2016), British Journal of Clinical Pharmacology, 81, 56 - 61
-
Joining the DoTS: new approach to classifying adverse drug reactions.
Journal article
Aronson JK. and Ferner RE., (2003), BMJ, 327, 1222 - 1225
-
EIDOS: a mechanistic classification of adverse drug effects.
Journal article
Ferner RE. and Aronson JK., (2010), Drug Saf, 33, 15 - 23
-
Toward standardized reporting of drug interactions: The READI checklist for anecdotal reports
Journal article
(2015), Expert Review of Clinical Pharmacology, 8, 399 - 409
-
The need for randomization in animal trials: An overview of systematic reviews
Journal article
Hirst JA. et al, (2014), PLoS ONE, 9
-
Can understanding mechanisms solve the problem of extrapolating from study to target populations (the problem of 'external validity')?
Journal article
(2013), Journal of the Royal Society of Medicine, 106, 81 - 86
-
Distinguishing hazards and harms, adverse drug effects and adverse drug reactions : implications for drug development, clinical trials, pharmacovigilance, biomarkers, and monitoring.
Journal article
Aronson JK., (2013), Drug Saf, 36, 147 - 153
-
A new taxonomy for describing and defining adherence to medications
Journal article
(2012), British Journal of Clinical Pharmacology, 73, 691 - 705
Recent publications
-
A systematic narrative review of coroners’ prevention of future deaths reports (PFDs): a potential metric for patient safety in hospitals
Preprint
Bremner BT. et al, (2023)
-
When I use a word . . . Medical definitions: Goldfinger events
Journal article
Aronson JK., (2023), BMJ, p1161 - p1161
-
CARE Guidelines for Case Reports: Explanation and Elaboration Document. Translation into Russian
Journal article
Riley DS. et al, (2023), Current Pediatrics, 22, 88 - 108
-
When I use a word . . . Medical definitions: Pharmacovigilance signals
Journal article
Aronson JK., (2023), BMJ, p1032 - p1032
-
When I use a word . . . Medical definitions: Pharmacovigilant surveillance.
Journal article
Aronson JK., (2023), BMJ, 381
-
When I use a word . . . Medical definitions: Pharmacovigilance
Journal article
Aronson JK., (2023), BMJ, p855 - p855
-
When I use a word . . . Medical definitions: adverse events, effects, and reactions.
Journal article
Aronson JK., (2023), BMJ (Clinical research ed.), 381
-
When I use a word . . . .Devising bioscience definitions.
Journal article
Aronson JK., (2023), BMJ, 380
-
When I use a word . . . .Diagnosing definitions.
Journal article
Aronson JK., (2023), BMJ, 380
-
When I use a word . . . . Defining with finesse
Journal article
Aronson JK., (2023), BMJ, p649 - p649